HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Provost Selected Research

eptapirone

3/20095-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Provost Research Topics

Disease

2Renovascular Hypertension (Goldblatt Syndrome)
04/2011 - 03/2009
2Hypertension (High Blood Pressure)
03/2009 - 03/2009
1Fibrosis (Cirrhosis)
04/2011
1Premature Cardiac Complexes (Extrasystoles)
03/2009
1Heart Arrest (Cardiac Arrest)
03/2009
1Renal Artery Obstruction (Renal Artery Stenosis)
03/2009
1Tachycardia (Tachyarrhythmias)
03/2009
1Weight Loss (Weight Reduction)
03/2009
1Ventricular Tachycardia
03/2009
1Cardiovascular Diseases (Cardiovascular Disease)
03/2009

Drug/Important Bio-Agent (IBA)

2Losartan (Cozaar)FDA LinkGeneric
04/2011 - 03/2009
1Desoxycorticosterone (Deoxycorticosterone)IBA
03/2009
1Digoxin (Digitek)FDA LinkGeneric
03/2009
1Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2009
1SaltsIBA
03/2009
1Endothelins (Endothelin)IBA
03/2009
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
03/2009
1sibutramine (Meridia)FDA Link
03/2009
1Desoxycorticosterone Acetate (DOCA)FDA Link
03/2009
1eptapironeIBA
03/2009
1Acetates (Acetic Acid Esters)FDA Link
03/2009
1Antihypertensive Agents (Antihypertensives)IBA
03/2009

Therapy/Procedure

1Surgical Instruments (Clip)
04/2011
1Intravenous Infusions
03/2009